What to Disclose and When: SEC Corporate Filings in the Time of COVID-19

July 14, 2020
Princeton Innovation Center BioLabs and Fox Rothschild LLP

The coronavirus pandemic has presented corporate compliance professionals with unprecedented issues affecting disclosures, filings and other SEC requirements, and the second quarter deadline for Form 10-Qs is rapidly approaching.

Join Fox attorney Jesse Fishman for a webinar, hosted in conjunction with Princeton Innovation Center BioLabs, on the critical points of the SEC’s guidance regarding companies’ 10-Q and other periodic filings.

Topics include:

  • SEC guidance contained in CF Disclosure Guidance Topic #9 and its impact on forward-looking statements, MD&A and disclosure controls and procedures
  • Filing an extension for additional time to file your Form 10-Q, 10-K and certain other periodic reports
  • Is it necessary to disclose if your CEO or other officers have COVID-19?
  • Effects on periodic reports, proxy statements and other information that needs to be disclosed by companies
  • Virtual shareholder meetings